Transce3nd’s Abbott ABT Stock Holding History

Transce3nd’s Portfolio ABT Stock Details ABT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-1,189	Closed	-$162K	–	164
2025 Q2	$162K	Sell	1,189 -44	-4%	-$5.8K	0.07%	161
2025 Q1	$164K	Sell	1,233 -160	-11%	-$20.4K	0.07%	158
2024 Q4	$158K	Buy	+1,393	New	+$161K	0.05%	196

Other funds holding ABT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Transce3nd's ABT Position: Q3 2025 in Review

Transce3nd sold out of Abbott (ABT) in Q3 2025, closing a stake of 1,189 shares — an estimated $162K sold.

Transce3nd first reported a position in ABT in Q4 2024 and held it in 3 quarters. The position peaked at $164K in Q1 2025. 3,181 funds tracked by Wall St. Rank hold ABT as of Q3 2025.

Transce3nd reported no remaining Abbott position as of Q3 2025 after selling out during the quarter.
Transce3nd sold 1,189 Abbott shares in Q3 2025, an estimated $162K.
Transce3nd first reported a position in Abbott in Q4 2024 and held it in 3 quarters.
Transce3nd's Abbott position peaked at $164K in Q1 2025.
3,181 funds tracked by Wall St. Rank held Abbott as of Q3 2025.

Based on Transce3nd's 13F filing for Q3 2025, filed 12 Nov 2025.